tiprankstipranks
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market
BUX
BioMark Diagnostics
RESEARCH TOOLSreports
Want to see TSE:BUX full AI Analyst Report?

BioMark Diagnostics (BUX) Stock News & Sentiment

3 Followers
BioMark to Showcase Home-Based Lung Cancer Blood Test at Canadian Thoracic Forum
Premium
Company Announcements
BioMark to Showcase Home-Based Lung Cancer Blood Test at Canadian Thoracic Forum
24d ago
BioMark Wins Peer-Reviewed Validation for AI-Driven Lung Cancer Detection Model
Premium
Company Announcements
BioMark Wins Peer-Reviewed Validation for AI-Driven Lung Cancer Detection Model
4M ago
BioMark Wins Peer-Reviewed Validation for AI-Driven Lung Cancer Detection Model
Premium
Company Announcements
BioMark Wins Peer-Reviewed Validation for AI-Driven Lung Cancer Detection Model
4M ago
BioMark Leverages Landmark Lung Cancer Studies and New Funding to Drive 2026 Expansion
Premium
Company Announcements
BioMark Leverages Landmark Lung Cancer Studies and New Funding to Drive 2026 Expansion
4M ago
BioMark Adds AI-Focused Investor James Lavender to Board to Drive U.S. Expansion
Premium
Company Announcements
BioMark Adds AI-Focused Investor James Lavender to Board to Drive U.S. Expansion
4M ago
BioMark Launches ISO 15189 Accreditation Drive to Accelerate Global Commercialization
Premium
Company Announcements
BioMark Launches ISO 15189 Accreditation Drive to Accelerate Global Commercialization
5M ago
BioMark Diagnostics Wins Innovation Award for Lung Cancer Screening Project
Premium
Company Announcements
BioMark Diagnostics Wins Innovation Award for Lung Cancer Screening Project
5M ago
More TSE:BUX News >

BUX News on the Web

BioMark to Showcase Home-Based Lung Cancer Blood Test at Canadian Thoracic Forum
TipRanks News
Bullish
European Penny Stocks To Watch: 3 Picks Below €30M Market Cap
Simply Wall St
Neutral
BioMark Wins Peer-Reviewed Validation for AI-Driven Lung Cancer Detection Model
TipRanks News
Neutral
Biomark Diagnostics Full Year 2025 Earnings: CA$0.021 loss per share (vs CA$0.017 loss in FY 2024)
Simply Wall St
Neutral
Biomark Diagnostics Second Quarter 2024 Earnings: CA$0.003 loss per share (vs CA$0.006 loss in 2Q 2023)
Simply Wall St
Neutral
Biomark Diagnostics Full Year 2023 Earnings: CA$0.022 loss per share (vs CA$0.02 loss in FY 2022)
Simply Wall St
Neutral

News Score - Last 7 Days

Neutral
TSE:BUX
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:BUX’s Media Buzz Sentiment?
1 articles about TSE:BUX were published this week. In an average week, 0.25 articles are published.
    What is TSE:BUX’s weekly average amount of articles?
    In an average week, 0.25 articles about TSE:BUX are published.
      What is TSE:BUX’s News Sentiment?
      100% of articles about TSE:BUX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week